The focus for HPV genotyping has largely been on types 16 and 18, based on their high
prevalence in cervix cancer. However screening is focussed on the detection of high grade …

Background HR HPV genotypes when assayed collectively, achieve high sensitivity but low
specificity for the prediction of CIN2+. Knowledge of the specific genotypes in an infection …

Classification of high‐risk HPV types for cervical cancer screening depends on
epidemiological studies defining HPV type‐specific risk. The genotyping tests that are used …

The effective management of women with human papillomavirus (HPV)-positive, cytology-
negative results is critical to the introduction of HPV testing into cervical screening. HPV …

In the last decade, the detection of human papillomaviruses (HPV) has become increasingly
important in cervical cancer screening and the treatment of cancer precursors. HPV …

Since 2012, testing high‐risk (HR) HPV has been used as the primary screening test for
women≥ 35 years attending the organized cervical cancer screening program in the city of …

Human papilloma virus (HPV) testing is more sensitive but less specific than cytology. We
evaluated stand‐alone genotyping as a possible triage method. During a multicentre …

Abstract Background: The cobas HPV Test (“cobas”; Roche Molecular Systems) detects
HPV16 and HPV18 individually, and a pool of 12 other high-risk (HR) HPV types. The test is …

Objective We assessed the age-related prevalence of high risk human papillomavirus (HR-
HPV) genotypes and the genotype-associated risk for high-grade cervical intraepithelial …

Objective Thirteen human papillomavirus (HPV) genotypes are associated with the highest
risk of cervical disease/cancer; however, the risk of disease progression and cancer is …